Literature DB >> 7474124

Differences in the role of the cytoplasmic domain of human parainfluenza virus fusion proteins.

Q Yao1, R W Compans.   

Abstract

We have investigated the roles of the cytoplasmic domains of the human parainfluenza virus type 2 (PI2) and type 3 (PI3) fusion (F) proteins in protein transport and cell fusion activity. By using the vaccinia virus-T7 transient expression system, a series of F protein cytoplasmic tail truncation mutants was studied with respect to intracellular and surface expression and the ability to induce cell fusion when coexpressed with the corresponding hemagglutinin-neuraminidase (HN) proteins. All of the cytoplasmic tail truncation mutants of PI2F were expressed at high levels intracellularly or on cell surfaces as measured by immunoprecipitation and cell surface biotinylation assays. In addition, when coexpressed with PI2HN, these truncation mutants of PI2F were all found to be essentially unimpaired in the ability to induce cell fusion as measured by a quantitative cell fusion assay. In contrast, surface expression and cell fusion activity were found to be eliminated by a mutant of PI3F in which the entire cytoplasmic tail was deleted, and the mutant protein appeared to be unable to assemble into a high-molecular-weight oligomeric structure. To further investigate whether there is a specific sequence requirement in the cytoplasmic tail of PI3F, a chimeric protein consisting of the PI3F extracellular and transmembrane domains and the PI2F cytoplasmic tail was constructed. This chimeric protein was detected on the surface, and it was capable of inducing cell fusion when expressed together with PI3HN, although the fusogenic activity was reduced compared with that of wild-type PI3F. These results demonstrate that although PI2 and PI3 viruses belong to the same parainfluenza virus genus, these viruses show marked differences with respect to functional requirements for the cytoplasmic tail of the F glycoprotein.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7474124      PMCID: PMC189624     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  Identification of biological activities of paramyxovirus glycoproteins. Activation of cell fusion, hemolysis, and infectivity of proteolytic cleavage of an inactive precursor protein of Sendai virus.

Authors:  A Scheid; P W Choppin
Journal:  Virology       Date:  1974-02       Impact factor: 3.616

2.  Expression from cloned cDNA of cell-surface secreted forms of the glycoprotein of vesicular stomatitis virus in eucaryotic cells.

Authors:  J K Rose; J E Bergmann
Journal:  Cell       Date:  1982-10       Impact factor: 41.582

3.  Expression and function of transplantation antigens with altered or deleted cytoplasmic domains.

Authors:  M C Zuniga; B Malissen; M McMillan; P R Brayton; S S Clark; J Forman; L Hood
Journal:  Cell       Date:  1983-09       Impact factor: 41.582

4.  Purification and characterization of the respiratory syncytial virus fusion protein.

Authors:  E E Walsh; M W Brandriss; J J Schlesinger
Journal:  J Gen Virol       Date:  1985-03       Impact factor: 3.891

Review 5.  The role of viral glycoproteins in adsorption, penetration, and pathogenicity of viruses.

Authors:  P W Choppin; A Scheid
Journal:  Rev Infect Dis       Date:  1980 Jan-Feb

6.  Construction, expression and recognition of an H-2 molecule lacking its carboxyl terminus.

Authors:  C Murre; C S Reiss; C Bernabeu; L B Chen; S J Burakoff; J G Seidman
Journal:  Nature       Date:  1984 Feb 2-8       Impact factor: 49.962

7.  Cell surface expression of the influenza virus hemagglutinin requires the hydrophobic carboxy-terminal sequences.

Authors:  M M Sveda; L J Markoff; C J Lai
Journal:  Cell       Date:  1982-09       Impact factor: 41.582

8.  Altered cytoplasmic domains affect intracellular transport of the vesicular stomatitis virus glycoprotein.

Authors:  J K Rose; J E Bergmann
Journal:  Cell       Date:  1983-09       Impact factor: 41.582

9.  Expression of wild-type and mutant forms of influenza hemagglutinin: the role of folding in intracellular transport.

Authors:  M J Gething; K McCammon; J Sambrook
Journal:  Cell       Date:  1986-09-12       Impact factor: 41.582

10.  Expression of Semliki Forest virus proteins from cloned complementary DNA. II. The membrane-spanning glycoprotein E2 is transported to the cell surface without its normal cytoplasmic domain.

Authors:  H Garoff; C Kondor-Koch; R Pettersson; B Burke
Journal:  J Cell Biol       Date:  1983-09       Impact factor: 10.539

View more
  30 in total

1.  Identification of domains on the fusion (F) protein trimer that influence the hemagglutinin-neuraminidase specificity of the f protein in mediating cell-cell fusion.

Authors:  Masato Tsurudome; Morihiro Ito; Machiko Nishio; Mito Nakahashi; Mitsuo Kawano; Hiroshi Komada; Tetsuya Nosaka; Yasuhiko Ito
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

2.  Activation of fusion by the SER virus F protein: a low-pH-dependent paramyxovirus entry process.

Authors:  Shaguna Seth; Annelet Vincent; R W Compans
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

3.  Characterization of a cytolytic strain of equine infectious anemia virus.

Authors:  Wendy Maury; Patrick J Wright; Sarahann Bradley
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

4.  Mutations in multiple domains activate paramyxovirus F protein-induced fusion.

Authors:  Shaguna Seth; Andrew L Goodman; Richard W Compans
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

Review 5.  Baculovirus as a vaccine vector.

Authors:  Hsin-Yu Lu; Yi-Hsuan Chen; Hung-Jen Liu
Journal:  Bioengineered       Date:  2012-06-18       Impact factor: 3.269

6.  C-terminal tyrosine residues modulate the fusion activity of the Hendra virus fusion protein.

Authors:  Andreea Popa; Cara Teresia Pager; Rebecca Ellis Dutch
Journal:  Biochemistry       Date:  2011-01-20       Impact factor: 3.162

7.  Analysis of the murine leukemia virus R peptide: delineation of the molecular determinants which are important for its fusion inhibition activity.

Authors:  C Yang; R W Compans
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

8.  Fusogenic variants of a noncytopathic paramyxovirus.

Authors:  Shaguna Seth; Ioanna Skountzou; Kim M Gernert; Richard W Compans
Journal:  J Virol       Date:  2007-02-07       Impact factor: 5.103

9.  Multifaceted sequence-dependent and -independent roles for reovirus FAST protein cytoplasmic tails in fusion pore formation and syncytiogenesis.

Authors:  Christopher Barry; Roy Duncan
Journal:  J Virol       Date:  2009-09-16       Impact factor: 5.103

10.  Murine leukemia virus R Peptide inhibits influenza virus hemagglutinin-induced membrane fusion.

Authors:  Min Li; Zhu-Nan Li; Qizhi Yao; Chinglai Yang; David A Steinhauer; Richard W Compans
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.